These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 790687)

  • 1. Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.
    Takahashi M; Czop J; Ferreira A; Nussenzweig V
    Transplant Rev; 1976; 32():121-39. PubMed ID: 790687
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 3. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
    Takahashi M; Tack BF; Nussenzweig V
    J Exp Med; 1977 Jan; 145(1):86-100. PubMed ID: 830792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
    Spitzer R; Stitzel A; Florio L; Urmson J
    Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
    [No Abstract]   [Full Text] [Related]  

  • 5. [New biological activity of complement and solubilization of immune complexes].
    Takahashi M
    Nihon Rinsho; 1979 May; 37(5):963-8. PubMed ID: 381727
    [No Abstract]   [Full Text] [Related]  

  • 6. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of complement in the induction of immunological responses.
    Pepys MB
    Transplant Rev; 1976; 32():93-120. PubMed ID: 790690
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of solubilization of immune precipitates by serum.
    Czop J; Nussenzweig V
    J Exp Med; 1976 Mar; 143(3):615-30. PubMed ID: 1249522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human complement system.
    Volanakis JE
    J Oral Pathol; 1975; 4(4):195-221. PubMed ID: 811779
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement function and disorders.
    Kehoe JM
    Pediatr Ann; 1976 Jun; 5(6):397-404. PubMed ID: 1272620
    [No Abstract]   [Full Text] [Related]  

  • 12. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.
    Theofilopoulos AN; Perrin LH
    Science; 1977 Mar; 195(4281):878-80. PubMed ID: 402691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
    Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
    J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
    Schifferli JA; Steiger G; Hauptmann G; Spaeth PJ; Sjöholm AG
    J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates.
    Johnston A; Auda GR; Kerr MA; Steward MW; Whaley K
    Mol Immunol; 1992 May; 29(5):659-65. PubMed ID: 1584232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human erythrocytes inhibit complement-mediated solubilization of immune complexes.
    Dorval BL; Cosio FG; Birmingham DJ; Hebert LA
    J Immunol; 1989 Apr; 142(8):2721-7. PubMed ID: 2522967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and function of the complement system.
    Müller-Eberhard HJ
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.